In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Grail Bio spins out of Illumina, raises over $100mm through Series A round

Executive Summary

Illumina Inc. spun out a new cancer testing company Grail Bio and participated in the company's Series A round of over $100mm. (Arch Venture Partners, Bezos Expeditions, Bill Gates, and Sutter Hill Ventures also took part in the financing.)
Deal Industry
  • Biotechnology
  • In Vitro Diagnostics
    • Molecular Diagnostics & Genetic Testing
Deal Status
  • Final
Deal Type
  • Financing
    • Spin-Off
    • Private Placement

Related Companies